Andrew Bouldin Named Principal at FCA Venture Partners
FCA Venture Partners, the venture capital manager of investment firm Clayton Associates, announced today that Andrew Bouldin has been promoted to Principal.
Andrew joined FCA in 2010 as an associate. His work is primarily focused on FCA’s most recent fund, FCA V, a $53M fund investing in the healthcare services and information technologies industries, targeting early to growth stage businesses led by strong management teams with capital efficient, scalable, and disruptive business models.
Read More
NuScriptRX names new CEO
Nashville-based NuScriptRX has named a new chief executive officer.
C. Daniel Haron, formerly president of Cigna Pharmacy Management, is the mail-orderinstitutional pharmacy’s new CEO, according toa news release. Haron replaces board memberDonald Taylor, who has served as interim CEO since July 2012.
Read More
Clatyon Associates Hosts CEO Forum
Last November, Clayton Associates hosted a CEO Forum with the management teams of all of its healthcare related portfolio companies.
The featured guest were Bill Carpenter, CEO of LifePoint Hospitals, and Bill Rutherford, CFO of Hospital Corporation of America.
Read More
Gemino Healthcare Finance Acquired by Solar Senior Capital
Gemino Healthcare Finance ("Gemino") today announced it has been acquired by Solar Senior Capital Ltd. (SUNS) ("Solar Senior Capital"). Over the last seven years, Philadelphia-based Gemino has earned a strong reputation in the market as a provider of asset-based and term financing solutions for small to mid-size healthcare companies.
Read More
Clinical Ink Announces $4.3M Equity Round Led by FCA Venture Partners
Clinical Ink, the pioneering provider of eSource solutions for clinical trials, has announced a $4.3M Series B Investment Round led by FCA Venture Partners. “This infusion of funds will allow Clinical Ink to aggressively build the capabilities needed to address the rapidly increasing customer demand for eSource technology in clinical trials,” said Ed Seguine, CEO of Clinical Ink. “Our business has more than doubled in the last year and we will be expanding our management team, development capabilities, and implementation resources to support a wider range of clinical trials globally. Our customers, from large pharma to small biotech, have achieved real productivity gains at a fraction of the cost of current solutions and we will be in a position to continue to support innovative approaches to remote monitoring, site selection, and data management.”
Read More
Aspire Health: Aspirational Care for the Seriously Ill
The palliative medicine company, noted Frist, has the potential to revolutionize advanced illness care in the United States … much the way hospice did for terminally ill patients nearly 40 years ago. Launched in Nashville, the plan is to create outpatient palliative care clinics and a physician network across the nation to better manage symptoms associated with life-threatening illness and chronic disease to improve outcomes and decrease costs associated with hospitalizations and Emergency Room visits. As Frist noted on the corporate website, “Advanced illness management is one of the few areas in healthcare where patients, caregivers, physicians, and health plan’s incentives are well aligned.”
Read More
Catavolt Raises $5M Series B Investment For Secure Enterprise Mobility Platform
Catavolt, Inc., creator of the world's first cloud middleware enterprise mobility platform, today announced the close of a $5M Series B investment round. San Francisco-based, Toba Capital, recently formed by Vinny Smith, former CEO and Founder of Quest Software, led the round in cooperation with Nashville, Tennessee-based FCA Venture Partners, an existing investor in Catavolt and Series A participant. The capital received from this round will be used to expand the sales organization, market the company's cloud middleware platform more aggressively, and further expand the product innovation team.
Read More
FCA Venture Partners Raises $53 Million Fund
FCA Venture Partners (“FCA”), the venture capital manager of investment firm Clayton Associates, announced the closing of its fifth fund, FCA Venture Partners V, L.P. (“FCA V” or the “Fund”), which exceeded its target with total commitments of $53 million.
FCA V is led by partners Matthew King and John Burch, along with CFO and partner Nancy Allen, who have more than 70 years combined operational and investment experience.
“We are very pleased with the continued support from our existing investors, many of whom have recommitted following investments in previous funds, which, along with a large number of new investors to the Fund, has dramatically increased our investor base,” said John Burch, Partner of FCA Venture Partners. FCA V’s Limited Partners include regional banks, leading asset management firms, family offices, entrepreneurs, and high net worth individuals.
Read More
